The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression

被引:68
作者
Azzoni, Adriano R. [1 ]
Ribeiro, Sofia C. [1 ]
Monteiro, Gabriel A. [1 ]
Prazeres, Duarte M. F. [1 ]
机构
[1] Univ Tecn Lisboa, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Inst Super Tecn, P-1049001 Lisbon, Portugal
关键词
plasmid DNA vectors; polyadenylation signal; nuclease resistance; reporter protein expression; mRNA maturation; DNA vaccines; gene therapy;
D O I
10.1002/jgm.1031
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Efficient delivery and expression of plasmids (pDNA) is a major concern in gene therapy and DNA vaccination using non-viral vectors. Besides the use of adjuvants, the pDNA vector itself can be designed to maximize survival in nuclease-rich environments. Homopurine-rich tracts in polyadenylation sequences have been previously shown to be especially important in pDNA resistance. Methodology The effect of modifications in the poly A sequence of a model pDNA vector (pVAX1GFP) on nuclease resistance and transgene expression was investigated. Four poly A sequences were studied: bovine growth hormone (BGH), mutantBGH, SV40 and a synthetic poly A. Plasmid resistance (half-life) was assessed through in vitro incubations with mammalian nucleases. The impact in transgene expression was studied by quantifying pDNA, mRNA, and GFP expression in CHO, hybridoma and HeLa cells. Results and conclusions In vitro and cell culture studies indicate that plasmids containing the SV40 and the synthetic poly A sequences present significant improvements in nuclease resistance (up to two-fold increase in half-life). However, RT-PCR analysis demonstrated that significant reduction in mRNA steady-state levels were responsible for a decrease in transgene expression and detected transfection level of CHO and hybridoma cells when using the more resistant plasmids. Interestingly, transfection of HeLa cells demonstrated that both poly A efficiency and plasmid resistance interfere significantly in transgene expression. The results strongly suggest that the choice of the poly A is important, not only for mRNA maturation/stability, but also for pDNA resistance, and should thus be taken into consideration in the design and evaluation of pDNA vectors. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:392 / 402
页数:11
相关论文
共 26 条
[11]  
LECHARDEUR D, 2002, CURR GENE THER, V2, P1
[12]   DEFINITION OF AN EFFICIENT SYNTHETIC POLY(A) SITE [J].
LEVITT, N ;
BRIGGS, D ;
GIL, A ;
PROUDFOOT, NJ .
GENES & DEVELOPMENT, 1989, 3 (07) :1019-1025
[13]   CANCER GENE-THERAPY USING PLASMID DNA - PHARMACOKINETIC STUDY OF DNA FOLLOWING INJECTION IN MICE [J].
LEW, D ;
PARKER, SE ;
LATIMER, T ;
ABAI, AM ;
KUWAHARARUNDELL, A ;
DOH, SG ;
YANG, ZY ;
LAFACE, D ;
GROMKOWSKI, SH ;
NABEL, GJ ;
MANTHORPE, M ;
NORMAN, J .
HUMAN GENE THERAPY, 1995, 6 (05) :553-564
[14]   Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero [J].
Lipshutz, GS ;
Titre, D ;
Brindle, M ;
Bisconte, AR ;
Contag, CH ;
Gaensler, KML .
MOLECULAR THERAPY, 2003, 8 (01) :90-98
[15]   Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes [J].
Oh, YK ;
Kim, JP ;
Yoon, H ;
Kim, JM ;
Yang, JS ;
Kim, CK .
GENE THERAPY, 2001, 8 (20) :1587-1592
[16]   Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids [J].
Pollard, H ;
Toumaniantz, G ;
Amos, JL ;
Avet-Loiseau, H ;
Guihard, G ;
Behr, JP ;
Escande, D .
JOURNAL OF GENE MEDICINE, 2001, 3 (02) :153-164
[17]   Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes [J].
Remaut, Katrien ;
Sanders, Niek N. ;
Fayazpour, Farzaneh ;
Demeester, Jozef ;
De Smedt, Stefaan C. .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (03) :335-343
[18]   The role of polyadenytation signal secondary structures on the resistance of plasmid vectors to nucleases [J].
Ribeiro, SC ;
Monteiro, GA ;
Prazeres, DMF .
JOURNAL OF GENE MEDICINE, 2004, 6 (05) :565-573
[19]   Gene medicines: The end of the beginning? [J].
Rolland, A .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (05) :669-673
[20]   Engineering synthetic vectors for improved DNA delivery: Insights from intracellular pathways [J].
Roth, CM ;
Sundaram, S .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 2004, 6 :397-426